An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Circulating tumor DNA (ctDNA) represents a promising biomarker for noninvasive assessment of cancer burden, but existing methods have insufficient sensitivity or patient coverage for broad clinical applicability. Here we introduce CAncer Personalized Profiling by deep Sequencing (CAPP-Seq), an econo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Newman, Aaron M., Bratman, Scott V., To, Jacqueline, Wynne, Jacob F., Eclov, Neville C. W., Modlin, Leslie A., Liu, Chih Long, Neal, Joel W., Wakelee, Heather A., Merritt, Robert E., Shrager, Joseph B., Loo, Billy W., Alizadeh, Ash A., Diehn, Maximilian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016134/
https://ncbi.nlm.nih.gov/pubmed/24705333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.3519
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller